A carregar...

Cytomegalovirus vaccine: phase II clinical trial results

Cytomegalovirus (CMV) is one of the most significant viral pathogens during pregnancy and in immunocompromised patients. Antiviral prophylactic strategies are limited by toxicities, drug–drug interactions and development of antiviral resistance. A safe and protective vaccine against CMV is highly de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Microbiol Infect
Main Authors: Rieder, F., Steininger, C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716458/
https://ncbi.nlm.nih.gov/pubmed/24283990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1469-0691.12449
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!